Conference
Economic evaluation of chemotherapy with Mitoxantrone plus Prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints
Authors
Bloomfield DJ; Krahn MD; Willan AR; Tannock IF
Volume
33
Pagination
pp. OP5-OP5
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
Publication Date
November 1, 1997
Conference proceedings
EUROPEAN JOURNAL OF CANCER
ISSN
0959-8049